Skip to content
OpenCapital
Get started

Ethos Technologies, Inc. LIFE Price / sales

Price / sales at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
2.6×-0.1×
Merck & Co. logo
Merck & Co.MRK
4.5×+1.0×
United Therapeutics logo
United TherapeuticsUTHR
8.2×+3.6×
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
9.5×-14.7×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
60×+58.2×
Zymeworks logo
ZymeworksZYME
22.9×+14.0×

Other financials

Income statement

See full
Revenue-—
Operating income-$11.4M+27.5%
Net income-$10.8M+27.5%
EPS (diluted)-$0.11+35.3%

Balance sheet

See full
Cash & equivalents$10.0M-3.4%
Total debt$12.3M-9.2%
Total equity$57.9M-22.8%
Total assets$79.7M-18.1%

Cash flow

See full
Operating cash flow-$12.5M+18.8%
CapEx$138.0K—
Free cash flow-$12.7M+17.9%

Valuation

See full
Market cap$1.14B+20.6%
Enterprise value$1.14B—

Profitability

See full
Operating margin-40,856.3%+28,833pp
Net margin-39,009.5%+29,653pp
FCF margin-32,664.7%+4,018pp

Returns & leverage

See full
Return on equity-105.3%+50.6pp
Debt / equity0.2×0.0×
Current ratio5.8×-2.0×